中藥湯劑聯合復方益母草膠囊治療剖宮產后惡露不絕臨床療效觀察
發(fā)布時間:2019-07-17 20:23
【摘要】:目的:探討自擬中藥湯劑聯合復方益母草膠囊治療剖宮產后惡露不絕患者臨床療效,并觀察患者治療前、后子宮三徑變化。方法:截選2014年1月—2016年1月326例于醫(yī)院行剖宮產分娩產婦進行研究,本次研究對象均出現產后惡露不絕(血熱型),其中以復方益母草膠囊治療者為對照組,5粒/次,2次/d;于對照組治療基礎上采用醫(yī)院自擬中藥湯劑治療者為治療組,兩組各163例。評價兩組患者治療前、后各項中醫(yī)證候積分變化,記錄兩組產后陰道出血時間,統計兩組臨床療效,并通過婦科檢查與盆底B超檢查患者治療前、后子宮三徑情況;記錄治療期間安全性。結果:治療組治療后中醫(yī)證候總積分為(1.63±0.38)分,明顯低于對照組(4.51±0.52)分,u=57.09,P=0.00;兩組患者治療后各項中醫(yī)證候積分明顯低于治療前,差異顯著具有統計學意義,P0.05。治療組陰道出血時間平均為(9.08±2.38)d,明顯短于對照組(11.29±3.02)d,u=7.33,P=0.00;治療組治療總有效率92.64%,明顯高于對照組81.60%,χ~2=12.25,P=0.00。治療組治療后子宮三徑和為(14.76±0.57)cm,明顯高于對照組(10.33±0.41)cm,u=80.55,P=0.00。兩組患者治療期間未發(fā)生明顯不良反應。結論:自擬中藥湯劑聯合復方益母草膠囊治療剖宮產后惡露不絕療效顯著,且可有利于促進患者臨床癥狀好轉,加速其產后子宮復舊,縮短產后惡露干凈時間。
[Abstract]:Objective: to investigate the clinical effect of self-made traditional Chinese medicine decoction combined with compound Yimucao capsule in the treatment of lox after cesarean section, and to observe the changes of uterus before and after treatment. Methods: from January 2014 to January 2016, 326 parturients undergoing cesarean section delivery in hospital were studied. The subjects of this study were postpartum lochia (blood-heat type), in which compound Yimucao capsule was used as the control group, 5 tablets per time, twice a day, and 163 cases in the treatment group were treated with hospital self-made traditional Chinese medicine decoction as the treatment group. To evaluate the changes of TCM syndrome scores before and after treatment in the two groups, to record the time of postpartum vaginal bleeding in the two groups, to count the clinical efficacy of the two groups, and to record the safety of the patients before and after treatment by gynecological examination and pelvic floor ultrasound examination. Results: the total score of TCM syndromes in the treatment group was (1.63 鹵0.38), which was significantly lower than that in the control group (4.51 鹵0.52), u 鈮,
本文編號:2515616
[Abstract]:Objective: to investigate the clinical effect of self-made traditional Chinese medicine decoction combined with compound Yimucao capsule in the treatment of lox after cesarean section, and to observe the changes of uterus before and after treatment. Methods: from January 2014 to January 2016, 326 parturients undergoing cesarean section delivery in hospital were studied. The subjects of this study were postpartum lochia (blood-heat type), in which compound Yimucao capsule was used as the control group, 5 tablets per time, twice a day, and 163 cases in the treatment group were treated with hospital self-made traditional Chinese medicine decoction as the treatment group. To evaluate the changes of TCM syndrome scores before and after treatment in the two groups, to record the time of postpartum vaginal bleeding in the two groups, to count the clinical efficacy of the two groups, and to record the safety of the patients before and after treatment by gynecological examination and pelvic floor ultrasound examination. Results: the total score of TCM syndromes in the treatment group was (1.63 鹵0.38), which was significantly lower than that in the control group (4.51 鹵0.52), u 鈮,
本文編號:2515616
本文鏈接:http://www.lk138.cn/zhongyixuelunwen/2515616.html
最近更新
教材專著